Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/21/2003CA2475522A1 Method of radio-labelling biomolecules
08/21/2003CA2475439A1 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003CA2475338A1 Treatment of ophthalmic disorders using urea and urea derivatives
08/21/2003CA2474844A1 Cks1 inhibitors
08/21/2003CA2474195A1 2-[5-(5-carbamimidoyl-1h-heteroaryl)]-6-hydroxybiphenyl-3-yl derivatives as factor viia inhibitors
08/21/2003CA2474171A1 Biphenil derivatives and their use as antiandrogenic agents
08/21/2003CA2473586A1 Treatment of sleep disorders using sleep target modulators
08/21/2003CA2472822A1 Chemical compounds
08/21/2003CA2472763A1 5-ht2b receptor antagonists
08/21/2003CA2472762A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/21/2003CA2472744A1 Oral solid solution formulation of a poorly water-soluble active substance
08/21/2003CA2472603A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
08/21/2003CA2462688A1 Partial dopamine-d2 receptor agonist plus serotonin and/or noradrenaline inhibitor activity
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003CA2372816A1 Aspirin containing composition for topical use and method of treatment
08/21/2003CA2372785A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
08/21/2003CA2372316A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
08/20/2003EP1336659A2 Process for recovering hydroperoxides
08/20/2003EP1336608A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives
08/20/2003EP1336607A1 Amide derivatives as glucokinase activators
08/20/2003EP1336604A1 Sulfoximine derivatives as MMP-inhibitors or antibiotics
08/20/2003EP1336602A1 Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1336413A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
08/20/2003EP1336408A1 Water-soluble liquid internal medicine
08/20/2003EP1336407A1 Medicinal compositions
08/20/2003EP1336406A1 Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitory activity
08/20/2003EP1336405A1 Formulations of atorvastatin stabilized with alkali metal additions
08/20/2003EP1335976A2 Modifier of organelle metalbolism
08/20/2003EP1335953A2 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use
08/20/2003EP1335939A1 Nitroderivatives of polysaccharides
08/20/2003EP1335924A2 Ethers of 7-desmethylrapamycin for use in immunosuppression
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335922A1 Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same
08/20/2003EP1335921A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
08/20/2003EP1335920A2 Small molecule compositions for binding to hsp90
08/20/2003EP1335919A1 Novel compounds
08/20/2003EP1335918A1 Novel compounds
08/20/2003EP1335917A2 Condensed pyridoindole derivatives
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
08/20/2003EP1335915A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
08/20/2003EP1335914A1 Triazole derivatives and pharmaceutical compositions comprising them
08/20/2003EP1335912A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors
08/20/2003EP1335908A2 Peroxisome proliferator activated receptor alpha agonists
08/20/2003EP1335907A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
08/20/2003EP1335906A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands
08/20/2003EP1335902A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP1335899A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003EP1335895A2 Protease inhibitors and their pharmaceutical uses
08/20/2003EP1335748A1 Antibiotic adducts with natural polysaccharide polymers in the form of aqueous solutions
08/20/2003EP1335747A1 A composition of sodium channel blocking compound
08/20/2003EP1335745A1 Use of a compound antagonist of the esm-1 protein for producing a medicine for treating cancer
08/20/2003EP1335740A1 Method and preparations having effect against allergic symptoms
08/20/2003EP1335738A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
08/20/2003EP1335733A1 Treatment of osteoporosis
08/20/2003EP1335732A2 Food item for increasing cognitive capacity
08/20/2003EP1335731A2 Antidiabetic compositions containing a biguanide and a sulfonamide
08/20/2003EP1335730A1 Treatment of premature ejaculation
08/20/2003EP1335729A2 Inhalative solution formulation containing a tiotropium salt
08/20/2003EP1335728A1 Novel medicament compositions based on tiotropium salts and on salmeterol salts
08/20/2003EP1335727A1 Method for inhibiting cataracts
08/20/2003EP1335726A1 Modified prodrug forms of ap/amp
08/20/2003EP1335725A2 Use of cci-779 as an antineoplastic agent
08/20/2003EP1335724A1 Novel use of certain insulin sensitizers or ppar-gamma agonists
08/20/2003EP1335723A1 Use of stimulators of soluble guanylate cyclase for treating osteoporosis
08/20/2003EP1335722A2 Compounds useful in the treatment of cns disorders
08/20/2003EP1335721A2 Method of treating and preventing migraine headaches
08/20/2003EP1335720A1 Sulphonamides for the treatment of central nervous system diseases
08/20/2003EP1335719A1 Treating eczema and/or psoriasis
08/20/2003EP1335718A1 6-methoxy-2-naphthylacetic acid prodrugs
08/20/2003EP1335717A1 Treatment of pcp addiction and pcp addiction-related behavior
08/20/2003EP1335716A1 Novel use of combined 5-ht 1a agonists and selective serotonin reuptake inhibitors
08/20/2003EP1335712A2 Multilayered supporting construction for plaster systems containing an active ingredient
08/20/2003EP1335711A2 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
08/20/2003EP1335709A2 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole
08/20/2003EP1335708A1 Controlled release metformin compositions
08/20/2003EP1335707A2 Novel formulations of carvedilol
08/20/2003EP1335704A2 Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
08/20/2003EP1335700A1 Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic or dermatological use
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1335689A1 Loratadine transdermal device and methods
08/20/2003EP1335687A2 Method for restoring a damaged or degenerated intervertebral disc
08/20/2003EP1335661A2 Production of microspheres
08/20/2003EP1263504B1 Use of compounds with 5-ht1a activity useful for treating disorders of the outer retina
08/20/2003EP1254139B1 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1212326A4 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
08/20/2003EP1194415B1 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation
08/20/2003EP1189908B1 Indolocarbazole alkaloids from a marine actinomycete
08/20/2003EP1173434B1 Thiazolidinedione derivative and its use as antidiabetic
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1165542B1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1143968B1 Composition and methods for administration of water-insoluble paclitaxel derivatives
08/20/2003EP1135110B1 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses
08/20/2003EP1133297B1 Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline
08/20/2003EP1128819B1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it
08/20/2003EP1121110B1 Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
1 ... 5370 5371 5372 5373 5374 5375 5376 5377 5378 5379 5380 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 ... 7860